Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Parasite study sheds light on anthelmintic resistance
The barber pole worm is resistant to major anthelmintics
Barber pole worm study offers hope for new treatments

A new study of the barber pole worm has offered insights into how treatments work and why anthelmintic resistance may occur.

Barber pole worm, or Haemonchus contortus, is a parasitic worm that lives in the gut of sheep and other livestock worldwide, and is now resistant to all major anthelmintics.

To find out how and why resistance has occurred, the research team studied a strain of H contortus that is susceptible to all major treatments for parasitic worms.

Scientists identified five enzymes key to the survival of the barber pole worm, two of which are already being studied as potential drug targets – one against another type of worm, the other against Mycobacterium tuberculosis.

According to funding institute the Wellcome Trust, the barber pole worm is endemic on all UK farms and is a significant threat to global food security. It is estimated to cost the UK sheep industry more than £80 million each year.

"Getting to grips with genomes such as that of H contortus is our best option to tackle the issue of drug resistance and develop new drugs against parasitic worms," said Professor Neil Sargison, study author from the University of Edinburgh's Royal (Dick) School of Veterinary Studies.

The research team also identified a set of genes that were more active within the parasite's gut, and at certain stages of its life cycle. It is hoped this information will offer a source of potential drug and vaccine candidates.

Co-author Professor Jon Gilleard, of the University of Calgary, said: "Not only is this worm closely related to many other parasites of livestock it is also similar to some species of worms in humans.

"This makes it an extremely important model parasite species for experimental studies. Revealing new drug targets against H contortus could provide much-needed new treatment opportunities against parasitic worms in both animals and humans."

 

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk